Royal DSM Pharmaceutical Products in Parsippany, a subsidiary of life sciences company Royal DSM in Herleen, The Netherlands, announced on Nov. 19 it would merge with fellow pharmaceutical company Patheon of Durham, N.C., in a $2.6 billion deal with Patheon’s parent company, private equity firm JLL Partners in New York City.

Vital Signs Bought for $500M

CareFusion Corp., a medical-technology company in San Diego, announced on Nov. 18 it bought Vital Signs of Totowa, a maker of respiratory medical products, from General Electric division GE Healthcare of Little Chalfont, U.K., for about $500 million.

Infinity Franchise Capital Acquired

This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.

To view this content, please continue to their sites.

Not a Lexis Subscriber?
Subscribe Now

Not a Bloomberg Law Subscriber?
Subscribe Now

Why am I seeing this?

LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.

For questions call 1-877-256-2472 or contact us at [email protected]